FDA Approved: LUTRATE DEPOT — Supplemental Application (Avyxa Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for LUTRATE DEPOT (leuprolide acetate) submitted by Avyxa Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• LUTRATE DEPOT (LEUPROLIDE ACETATE)

Snippet

SUPPL AP for LUTRATE DEPOT (LEUPROLIDE ACETATE)